Dr. Parul Thakral

First prize in the 3rd International Medical Olympiad for Contribution in Radioimmunotherapy in Oncology.

World Association of Radiopharmaceutical & Molecular Therapy European Association of Nuclear Medicine (EANM) Society of Nuclear Medicine - India

An approach for conjugation of 177Lu- DOTA-SCN- Rituximab (BioSim) and its evaluation for radioimmunotherapy of relapsed and refractory B-cell Non Hodgkins Lymphoma patients Feasibility of 18F-FDG Labelling of Leucocytes in a Centre Without an On-Site Cyclotron and Monitoring of Radiation Dose to Occupational Worker in the Labelling Procedure Dosimetric analyses of Kidneys, Liver, Spleen, Pituitary gland and Neuroendocrine tumors of patients treated with 177Lu-DOTATATE In-House Preparation and Quality Control of Ac-225 Prostate-Specific Membrane Antigen-617 for the Targeted Alpha Therapy of Castration-Resistant Prostate Carcinoma Preliminary professional experience with Yttrium-90-labelled Rituximab (chimeric anti CD-20 antibody) in patients with relapsed and refractory B cell NHL Radiation Dose to the Occupational Worker during the Synthesis of 188Re-labeled Radiopharmaceuticals in the Nuclear Medicine Department Radiation Exposure to the Nuclear Medicine Personnel During Preparation and Handling of 213Bi-Radiopharmaceuticals Charting the Course of Targeted ? Therapy With First-in-Human, Postadministration Image-Guided Dosimetry and Response Assessment of 212Pb-VMT-?-NET in Metastatic Neuroendocrine Tumors\ The Role of PET-CT-Guided Metabolic Biopsies in Improving Yield of Inconclusive Anatomical Biopsies: A Review of 5 Years in a Teaching Hosp. Validation of In-House Kit-Like Synthesis of 68Ga-Trivehexin and Its Biodistribution for Targeting the Integrin ?v?6 Expressing Tumors Upfront Use of 177Lu-Labeled PSMA Radioligand Therapy and Treatment Response Assessment in Treatment-Naive Prostate Cancer Dosimetric analyses of intra-arterial versus standard intravenous administration of 177Lu-DOTATATE in patients of well differentiated neuroendocrine tumor with liver-dominant metastatic disease Therapeutic efficacy of 225Ac-PSMA-617 targeted alpha therapy in patients of metastatic castrate resistant prostate cancer after taxane-based chemotherapy Incremental Value of Ga-68 Prostate-Specific Membrane Antigen-11 Positron-Emission Tomography/Computed Tomography Scan for Preoperative Risk Stratification of Prostate Cancer In-House Preparation and Quality Control of Ac-225 Prostate-Specific Membrane Antigen-617 for the Targeted Alpha Therapy of Castration-Resistant Prostate Carcinoma Molecular Imaging to the Surgeons Rescue: Gallium-68 DOTA-Exendin-4 Positron Emission Tomography-Computed Tomography in Pre-operative Localization of Insulinomas Radiation Exposure to the Nuclear Medicine Personnel During Preparation and Handling of 213Bi-Radiopharmaceuticals Dosimetric analysis of patients with gastro-entero-pancreatic neuro endocrine tumors (NETs) treated with PRCRT (Peptide Receptor Chemo Radionuclide Therapy) using Lu-177 DOTATATE and Capecitabine/Temozolamide (CAP/TEM) Radiation Dose to the Occupational Worker during the Synthesis of Re-labeled Radiopharmaceuticals in the Nuclear Medicine Department Rare sites of metastases in prostate cancer detected on Ga-68 PSMA PET/CT scan-a case series